TERRA levels in astrocytoma correlate with clinical grade, low or absent TA and the presence of ALT as determined by long telomere lengths [78], making TERRA transcripts a candidate as marker for favorable prognosis associated with GBM [142]. The gene discussed is GPT; the disease is glioblastoma.